MindMaze Therapeutics Holding S.A.
OTC: RLFTY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zach Henderson
- Employees
- 33
- Headquarters
- Geneva, Switzerland
- IPO year
- 2025
- Market cap
- $5.3M
- Website
- https://mindmazetherapeutics.com
Loading RLFTY…
Loading profile data…Frequently asked questions about RLFTY
What does MindMaze Therapeutics Holding S.A. (RLFTY) do?
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
Where does RLFTY trade?
MindMaze Therapeutics Holding S.A. (RLFTY) trades on the Other OTC.
What sector is RLFTY in?
MindMaze Therapeutics Holding S.A. (RLFTY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MindMaze Therapeutics Holding S.A.?
Zach Henderson is the chief executive officer of MindMaze Therapeutics Holding S.A. (RLFTY).
Where is MindMaze Therapeutics Holding S.A. headquartered?
MindMaze Therapeutics Holding S.A. is headquartered in Switzerland.
Does RLFTY pay a dividend?
MindMaze Therapeutics Holding S.A. (RLFTY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RLFTY go public?
MindMaze Therapeutics Holding S.A. (RLFTY) completed its initial public offering in 2025.